---
title: CDMO Daily News — September 12, 2026
slug: daily-news-2026-09-12-cdmo
site: cdmo
post_kind: news
byline: BioBM
description: September 12 CDMO daily: Samsung Biologics Secures $262M Long-Term Manufacturing Contract Through 2033 — Samsung Biologics' Songdo facility now carries…
canonical_url: https://www.cdmo.directory/posts/daily-news-2026-09-12-cdmo
published_at: 2026-09-12T00:00:49.235Z
last_updated: 2026-09-12T00:01:23.460Z
---

### [Samsung Biologics](/companies/samsungbiologics) Secures $262M Long-Term Manufacturing Contract Through 2033
- [Samsung Biologics](/companies/samsungbiologics) signed a $262 million manufacturing agreement with a European pharma company, with commitments extending through 2033 at its Songdo, South Korea facility.
- The deal brings Samsung Biologics' cumulative contract value to over $21.9 billion, reflecting sustained demand and rapid capacity booking across its global network.

**Operational Impact**

[Samsung Biologics](/companies/samsungbiologics)' Songdo facility now carries committed manufacturing through 2033, reducing available capacity for new client onboarding and reinforcing the company's position as a capacity-constrained CDMO vendor in the biologics market.

*Source: [Contract Pharma Breaking News RSS](https://www.contractpharma.com/breaking-news/samsung-biologics-signs-262m-manufacturing-deal-with-european-pharma-company)*

## References

1. [Contract Pharma Breaking News RSS — Samsung Biologics Secures $262M Long-Term Manufacturing Contract Through 2033](https://www.contractpharma.com/breaking-news/samsung-biologics-signs-262m-manufacturing-deal-with-european-pharma-company)

Source: https://www.cdmo.directory/posts/daily-news-2026-09-12-cdmo